Segment disclosures

Company overview

DOLBY LABORATORIES, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 14 retained observations 10 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dlb:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-09-27 – 2026-09-251420867000 USD20261117Open filing evidence
2026-03-28 – 2026-06-26304995000 USD20260730Open filing evidence
2025-09-27 – 2026-06-261047331000 USD20260730Open filing evidence
2025-12-27 – 2026-03-27395630000 USD20260430Open filing evidence
2025-09-27 – 2026-03-27742336000 USD20260430Open filing evidence
2025-09-27 – 2025-12-26346706000 USD20260129Open filing evidence
2024-09-28 – 2025-09-261349130000 USD20261117Open filing evidence
2025-03-29 – 2025-06-27315546000 USD20260730Open filing evidence
2024-09-28 – 2025-06-271042106000 USD20260730Open filing evidence
2024-12-28 – 2025-03-28369561000 USD20260430Open filing evidence
2024-09-28 – 2025-03-28726560000 USD20260430Open filing evidence
2024-09-28 – 2024-12-27356999000 USD20260129Open filing evidence
2023-09-30 – 2024-09-271273721000 USD20261117Open filing evidence
2022-10-01 – 2023-09-291299744000 USD20251118Open filing evidence